Fierce Biotech January 9, 2024
We’ve compiled the biggest medtech news coming from the 2024 J.P. Morgan Healthcare Conference, from in and around San Francisco and all points beyond.
Read on for our continuously updated collection of acquisitions, collaborations, curtain-raisings and presentations, all made bite-sized, and be sure to check out the daily roundups and all the coverage from our colleagues at Fierce Biotech, Fierce Pharma and Fierce Healthcare.
Boston Scientific looks to compete with Medtronic in yet another category, as it enters the sacral neuromodulation space with a $3.7 billion acquisition deal for the medtech giant’s rival Axonics and its portfolio of implants for urinary and fecal incontinence. Boston Scientific described the market as an “underpenetrated opportunity” that is expected to double in size...
Today's Sponsors
Today's Sponsor